Ontology highlight
ABSTRACT: Background
No present guidelines exist regarding the inclusion of atherogenic cancer or chemotherapy into atherosclerotic cardiovascular disease (ASCVD) screening or imaging screening guidelines. Individual physician preference often determines screening, and this is typically symptom guided.Case summary
A 30-year-old woman with early-stage breast cancer received atherogenic chemotherapy, with no prior atherogenic risk factors. She presented with angina and dyspnea on exertion 3 years after her last round of chemotherapy. An ischemic work-up was performed, and the patient was found to have premature critical stenosis in her proximal left anterior descending artery.Discussion
Because more patients are living with cancer and survivors of atherogenic chemotherapy emerg
SUBMITTER: Varkoly K
PROVIDER: S-EPMC12789770 | biostudies-literature | 2025 Sep
REPOSITORIES: biostudies-literature